Author Guidelines

Submission Preparation Checklist

As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.

    • That this manuscript is being submitted only to the International Journal of Maternal and Child Health and AIDS (IJMA), that this manuscript shall not be submitted elsewhere while under consideration, that it has not been published elsewhere, and, should it be published in IJMA, that it shall not be published elsewhere—either in similar form or verbatim—without permission of the editors. (Note: These restrictions do not apply to abstracts or to press reports of presentations at scientific meetings and conferences).

    • That all authors listed on this manuscript have made substantive intellectual contributions to the manuscript with regards to conception and design, acquisition of data, or analyses and interpretation of data, drafting the article or revising it critically for important intellectual content; and that they all have given final approval of the version to be submitted for publication.

    • That all authors have discussed and decided the authorship issues, including the order in which the authors would be listed in the published paper, before submission.

    • That all authors understand that IJMA is an open-access journal and that, if accepted for publication, we fully understand that we shall be required to pay an article-processing charge before the final publication of our paper.

    • That all authors have complied with the necessary local and international regulations regarding the conduct of research, including a declaration of conflict of interest, disclosure of financial interest, and institutional review board approval, where necessary, in the preparation of this manuscript. The text adheres to the stylistic and bibliographic requirements outlined in the Author Guidelines, which is found in About the Journal.

    • That the authors have obtained the necessary approvals in adherence with the local and international policies and used the standardized form of the International Committee of Medical Journal Editors and other ethical guidelines outlined by the journal and guiding the universal conduct of research; and shall make all efforts to submit any approvals, if needed.

    • That the manuscript document has been created using the IJMA Author Manuscript Template and that all tables and figures are included in ONE document file.

    • I agree that I am not allowed to withdraw the manuscript once a review has commenced unless for the written and documented purposes of addressing serious ethical violations identified after submission and in agreement with the Editor-in-Chief; I agree that the journal reserves the express right to publish the paper, charge the required article processing charges, or charge the submission fees to cover the cost of review resources.


Scroll to top

Section Policies

Submission

Manuscript submissions are free.

Prospective authors are highly encouraged to review every section of this author's instruction to ensure that they are submitting manuscripts that comply with the laid-out instructions. To say it simply, if you want your manuscript to be expedited, do your part and simply follow the instructions laid out in this document.

Author Manuscript Template

Download the IJMA Author Manuscript template on the journal's website.

Article Types

IJMA considers the following types of articles for publication:

Original Research Articles

These will be reports of data from original research conducted by researchers.

Methodology Articles

These comprise presentations of novel statistical, demographic, and public health applications and techniques, experimental methods, tests, or procedures. These articles must demonstrate how the new method improves upon what is currently in existence in the field of professional practice. Methodology articles undergo peer-review.

Short Research Communication

These are brief reports of data from original research. Authors of short research communications may be asked to sign an agreement to publish the full paper in IJMA before the publication of rapid communication. Short research communication undergoes peer review.

Case Reports

These are reports of medical cases that can be educational, describe a diagnostic or therapeutic dilemma, suggest an association, or present an important adverse reaction. Authors of all case report articles should indicate that informed consent to publish the information was granted from the patients or their guardians and must submit such authorization if requested. Case reports undergo peer review.

Field Studies or Case Studies

These are descriptions of a major program intervention or policy option that is adjudged to be relevant to the fields of MCH and HIV/AIDS. Case study articles should include a rigorous assessment of the processes and the impact of the study, as well as recommendations for the future. These undergo peer review.

Editorial or Commentaries

These are short, focused, and opinion articles addressing emerging issues in maternal, neonatal, and child health, HIV/AIDS, and social determinants of health. These usually set the stage for galvanizing further action in the issues addressed. These are peer-reviewed by at least one peer-reviewer.

Review Articles

These are comprehensive, authoritative, descriptions of any subject that addresses existing or emerging areas in all aspects of maternal, neonatal, and child health and HIV/AIDS. These can be systematic reviews or meta-analyses. IJMA complies with the international standards for reporting review articles. IJMA prefers that review articles conform to the PRISMA or other international standards for reporting systematic reviews. Please review the PRISMA statement here for more information about the PRISMA standard.

Book Reviews

These are short summaries of the strengths and weaknesses of a new book in the field evaluating the book’s usefulness in the fields of MCH and HIV/AIDS. Authors planning to submit book reviews should contact the editors before submission at submissions@mchandaids.org.

Letters to the Editor

These are published responses to articles previously published in the journal and responses by the authors of the work so-referred if the Letter to Editor substantially adds to the findings of the prior article in question. Letters to the Editor are limited to reactions to two prior issues of the journal. All Letters to the Editor are reviewed but are not peer-reviewed.

Conference Reports

These are short descriptions of a conference that the author has attended, which focuses on the key developments presented and discussed at the meeting. Meeting reports must address MCH and HIV/AIDS.

Special Collection or Supplements

IJMA welcomes inquiries about publishing special collections or supplements. The proposal to publish the contents, (articles or meeting abstracts) should be addressed to the Managing Editor. All Supplements are subject to the editorial policy and guidelines.


Scroll to top

Manuscript Preparation

IJMA accepts manuscripts written in American ENGLISH only. Manuscripts are to be typed double-spaced using American English spelling ONLY. Manuscripts that do not adhere to the word limits may be returned to the authors.

All manuscripts should be submitted by the corresponding author. Submissions by anyone other than the corresponding author will not be accepted. Manuscripts should be submitted as Microsoft Word document ONLY (no PDFs or other formats). All tables and figures should be incorporated into the same single document. Avoid the use of special formatting.

After submitting your manuscript, corresponding authors are advised to add the journal’s email address submissions@mchandaids.org to their email contacts. This will prevent emails from the journal from being delivered to your email spam/junk mailbox.


Manuscript Format

Title and Authorship Page

The title page should be single-spaced. It should contain the following information:

  • Manuscript title
  • Full name of authors including highest earned degrees and professional degrees only
  • Full institutional address of all authors (including ZIP code, if applicable)
  • Telephone number with area codes
  • E-mail addresses of all authors
  • Identification of one corresponding author with contact information (email address and telephone number(s)).

Abstract

The manuscript should contain an abstract. The abstract should be self-contained, free of citations, and not exceed 300 words. Abstracts should be structured with the following five sections:

(1) Background /Objectives, (2) Methods, (3) Results, (4) Discussion, (5) Conclusions, and Global Health Implications.


Background and Objectives

This section provides an introduction and overview including what is known in the field. It should be succinct, with no subheadings. This is where you state what is known in the field and what is lacking using if preferred the "deficiency model" in identifying gaps in current/prior research and practice. This is where you provide the statement of the problem followed by the objectives of your present study. This is where you make the argument why we should publish this paper.


Methods

This part should contain sufficient detail so that all procedures can be replicable by other researchers. Authors may divide this into subsections if several methods are described. The methodology should be precise but with sufficient detail to guide scientific replicability. It should not be laborious. If the method is well-known and described elsewhere, please refer your readers to those sources. Include information about the approval of the study stating which Institutional Review Board or Ethics Board approved the study or granted exception.


Results

This section may each be divided by subheadings or may be combined. It provides the findings of the study without discussions. Begin with the key findings and work down to the last finding. Please limit all numbers to two decimal places.


Discussion

The discussion section should be as concise as possible and should include a brief statement of the principal findings, a discussion of the validity of the observations, a discussion of the findings in light of other published work dealing with the same or closely related subjects, and a statement of the possible significance of the work. It should also include strengths and weaknesses of the paper and unanswered questions and future research. Extensive discussion of the literature is discouraged in this section.


Conclusions and Global Health Implications

You may decide to separate these into two sections or one section. This section should clearly explain the main conclusions of the work; it should highlight the work’s importance and relevance to both practice and policy. This section should address the “so what?” question addressed by the paper. What is the contribution that this paper will make to the field? This is also the place where limitations of the study, including but not limited to the design, methods, or dataset, should be discussed.


Key Words

Authors should provide a list of 6-12 keywords directly below the abstract. Keywords should express the precise content of the manuscript, as they are used for indexing and search purposes. To the extent possible, select keywords from the NIH Medical Subject Headings (MeSH).


Acknowledgment

Acknowledgment should be included at the end of the paper before the references. It should contain information about research support grants, fellowships, and presentations. This is a place to list contributors who do not meet the criteria for authorship such as people who provided technical help or writing assistance. Also, include here details of any organization that has contributed to your research such as funding organization. Authors are responsible for obtaining permissions from all the people acknowledged before putting their names in the manuscript.


Conflict of Interest

The author(s) should state if they have any conflict of interest regarding the paper. If there is, please state clearly what the conflict(s) is or are.


Funding

The authors should state the funding source, if applicable.


Key Messages

Include 3-6 bullet points of the major findings of your manuscript. These should be stated like elevator pitches which can be rehearsed within a short period of time. The key messages should come immediately before references.


Journal Style/Formatting

IJMA follows the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly work in Medical Journals as outlined by the International Committee of Medical Journal Editors (ICMJE).

All aspects of the manuscript, including the formatting of tables, illustrations, and references and grammar, punctuation, usage, and scientific writing style, should be prepared according to the most current AMA Manual of Style. The AMA (sometimes referred to as the JAMA) style is available in most reference management software such as EndNote, Reference Manager, etc.

References

Authors are responsible for ensuring that the information in each reference is complete and accurate. With the exception of review articles, manuscripts should have no more than 30 references.

References should follow the AMA Manual of Style, current edition. However, for IJMA, list all authors. Abbreviated journal names should follow the Index Medicus style.

References must be numbered consecutively and citations of references in text should be identified using numbers in superscript (e.g., “as discussed by Johnson;9” “as discussed elsewhere. 9, 10

All references should be cited within the text; otherwise, these references will be automatically removed from the manuscript. Authors are strongly advised to review any of the papers published in the journal for a sample of the article preparation. The editors reserve the right to delete references during the review process.

Note that punctuation marks come before the citation square brackets. Please minimize the use of internet references as these links on many occasions break and are no longer functional.


Sample AMA Style Citations and References

  1. Singh GK, Siapush M, Kogan MD. Rising social inequalities in US childhood obesity, 2003-2007. Ann Epidemiol. 2010; 20(1):40-52.
  2. Azuine MA, Tokuda H, Takayasu J, Enjyo F, Mukainaka T, Konoshima T, Nishino H, Kapadia GJ. Cancer chemopreventive effect of phenothiazines and related tri-heterocyclic analogues in the 12-O-tetradecanoylphorbol-13-acetate promoted Epstein-Barr virus early antigen activation and the mouse skin two-stage carcinogenesis models. Pharmacol Res. 2004; 49(2):161-169.
  3. Azuine R, Russell J, Clark S, O’Brien C, Rowell H, Lansdowne N. The outlook for a new generation. Nurs Times. 2004; 100(4):28-29.

Tables, Figures, and Illustrations

Tables and figures should be numbered and referred to by number in the text. Each table or figure should be typed on a separate page and should have a descriptive title. Attach the tables and the figures at the end of the manuscript after the references.

Illustrations (photographs, drawings, diagrams, and charts) are to be numbered in one consecutive series of Arabic numerals and referred to by number in the text. Photographs should be high-contrast and drawings should be dark, sharp, and clear.

Artwork for each figure should be provided on a separate page. Each figure should have an accompanying caption. The list of captions for illustrations should be typed on a separate page. There should be no more than three tables or figures for a full research paper. Extra tables and figures may be published at extra cost to the authors.


Units of Measurement

Authors of manuscripts are advised to present units of measurement using System International (SI) units.


Scroll to top

Reporting Guidelines

This journal adheres to the EQUATOR Network reporting guidelines
Article types are based upon key reporting guidelines, as defined by the EQUATOR Network. Authors should prepare their manuscripts in accordance with the appropriate guidelines(s) and/or checklist(s) for each type of article. We ask that authors use the checklist and flow diagram templates for the guidelines outlined below for each of the articles they are reporting. We ask that authors use the appropriate checklist (and flow diagram, if applicable) and include the checklist with each submission. Below you will find the reporting guidelines for the kinds of articles published by this journal.

For further information regarding reporting guidelines, authors should consult the EQUATOR Network website (http://www.equator-network.org), which maintains a useful, up-to-date list of guidelines as they are published, with links to articles and checklists.

Clinical Trial/Experimental Study (CONSORT Compliant)
Reports of randomized trials must conform to the revised CONSORT guidelines and should be submitted with their protocols and a completed CONSORT checklist. All reports of clinical trials must include a summary of previous research findings and explain how the submitted trial affects this summary of previous findings. Cluster randomized trials should be reported according to extended CONSORT guidelines. Randomized trials reporting harms must be described according to extended CONSORT guidelines. All reports of randomized trials should include a section entitled "Randomization and masking" within the methods section. For information regarding CONSORT guidelines, please visit http://www.consort-statement.org.

Observational Study (STROBE Compliant)*
Observational research comprises several study designs and many topic areas. The STROBE statement should be used when reporting such research. The STROBE recommendations apply to the three main analytical designs used in observational research: cohort, case-control, and cross-sectional studies. The STROBE Statement consists of a 22-item checklist. For information regarding STROBE guidelines, please visit http://www.strobe-statement.org.

*Please note that authors are allowed to use a customized version of the STROBE checklist.

Systematic Review and Meta-Analysis (PRISMA Compliant)
Systematic reviews and meta-analyses must be reported according to PRISMA guidelines, an evidence-based minimum set of items created to help authors improve the reporting of systematic reviews and meta-analyses. The PRISMA Statement consists of a 27-item checklist and a four-phase flow diagram. For information regarding PRISMA guidelines, please visit http://www.prisma-statement.org.

Meta-Analysis of Observational Studies in Epidemiology (MOOSE Compliant)

Systematic reviews and meta-analyses of observational studies in epidemiology should be reported according to MOOSE guidelines. For more information regarding MOOSE guidelines, please visit http://www.equatornetwork.org/reporting-guidelines/meta-analysis-of-observational-studies-in-epidemiology-a-proposal-forreporting-meta-analysis-of-observational-studies-in-epidemiology-moose-group/.

Diagnostic Accuracy Study (STARD Compliant)
Investigators reporting studies of diagnostic accuracy should adhere to the STARD statement, part of the STARD initiative to improve the accuracy and completeness of reporting of studies of diagnostic accuracy, to allow readers to assess the potential for bias in a study (internal validity) and to evaluate a study's generalizability (external validity). The STARD statement consists of a 25-item checklist and recommends the use of a flow diagram to describe the design of the study and the flow of patients. For information regarding STARD guidelines, please visit http://www.stard-statement.org.

Quality Improvement Study (SQUIRE Compliant)*
The SQUIRE statement helps authors write excellent, usable articles about quality improvement in health care so that findings may be easily discovered and widely disseminated. The SQUIRE statement consists of a 19-item checklist. The SQUIRE guidelines are not exclusive to other guidelines. For example, an improvement project or effectiveness study that used a randomized controlled trial design should consider using both the CONSORT and the SQUIRE guidelines. In these cases, both checklists should be uploaded as a single document. For more information regarding SQUIRE guidelines, please visit http://squire-statement.org/.

*Please note that authors are allowed to use a customized version of the SQUIRE checklist.

Economic Evaluation Study (CHEERS Compliant)
Developed by the ISPOR Quality Improvement in Cost-Effectiveness Research Task Force, the CHEERS statement supports the quality, consistency, and transparency of health economics and outcomes research reporting in the biomedical literature. The CHEERS statement includes a 24-item checklist. For more information regarding CHEERS guidelines, please visit http://www.ispor.org/taskforces/EconomicPubGuidelines.asp.

Clinical Case Report (CARE Compliant)
The CARE guidelines provide a framework to support the need for completeness, transparency, and data analysis in case reports and data from the point of care. The main tools of CARE are the CARE Statement, CARE checklist, and a Case Report Writing Template. These products offer a rationale and a standardized format for authors to prepare more complete and transparent case reports. For more information regarding CARE guidelines, please visit http://www.care-statement.org/.

Qualitative Studies (SRQR Compliant)

The Standards for Reporting Qualitative Research (SRQR) formulates and defines standards for reporting qualitative research while preserving the requisite flexibility to accommodate various paradigms, approaches, and methods. The SRQR aims to improve the transparency of all aspects of qualitative research by providing clear standards for reporting qualitative research. These standards will assist authors during manuscript preparation, editors and reviewers in evaluating a manuscript for potential publication, and readers when critically appraising, applying, and synthesizing study findings. The SRQR consists of 21 items. For more information regarding SRQR guidelines, please visit https://journals.lww.com/academicmedicine/fulltext/2014/09000/Standards_for_Reporting_Qualitative_Research__A.21.aspx


Scroll to top

Publication & Submission Policies

IJMA subscribes and will continue to subscribe, to the best ethical principles in the publication of scientific work. The policies published here are meant to provide general guidelines and are in tandem with the best practices adopted (and disseminated) by many prominent publishers, scientific journals, and scientific publication forums across the world. The policies outlined here are living policies and will thus be updated as necessary. Submission is a representation that the manuscript has not been published previously and is not currently under consideration for publication elsewhere (except in the form of an abstract or as part of a published lecture, review, final project, thesis, or dissertation). The corresponding author is responsible for ensuring that the article’s publication has been approved by all the other coauthors. It is also the authors’ responsibility to ensure that the articles emanating from a particular institution are submitted with the approval of the necessary institution. Only an acknowledgment from the IJMA editorial office officially establishes the date of receipt. Further correspondence and proofs will be sent to the corresponding author before publication unless otherwise indicated. It is a condition of submission of a paper that the authors permit editing of the paper for readability. All inquiries concerning manuscripts under consideration should be addressed to the editorial office via email submissions@mchandaids.org.

Peer Review

Every submission for a featured manuscript is evaluated by at least two reviewers. Reviewers help the Editor-in-Chief determine the paper’s relevance and significance, the degree to which it advances knowledge, the quality of scholarly presentation, the integrity of research methods, and content relevant to MCH and HIV/AIDS.


Scroll to top

Article Processing Charges

This journal is a non-profit Gold Open Access journal, which means it offsets all the costs associated with its high-quality publishing service through Article Processing Charges (APC). All manuscripts submitted to this journal are assumed to be submitted under the Open Access publishing model. In the Open Access publishing model, papers are peer-reviewed in the same normal rigorous review under editorial control. Once a paper is accepted for publication, the author will be issued with an invoice for payment of an APC. The APC is charged to the authors, institutions, or funders. Upon receipt of the APC, the paper will be scheduled for production.
APC allows our non-profit publisher to recover its editorial and production costs and create/support a pool of funds that is used to provide fee waivers and discounted APC rates for authors from developing countries of students. Published papers appear electronically and are freely available from our journal’s website for anyone in the world to read, distribute and reuse. Authors may also use the published PDF of their published papers for any non-commercial use on their personal or non-commercial institution's website. The table below contains the article processing charges (APCs) charged by the journal for accepted manuscripts.

 

Article Processing Charges (APC) Table (in U.S. Dollars)

Article Type

Developed Countries*

Developing Countries or LMIC

Letters to the Editor

Free

Free

Original Research

500

300

Editorials, Commentaries & Viewpoints

500

300

Short Research Communication

500

300

Field Studies, Notes from the Field, & Case Reports

500

300

Public Health Policy & Practice

500

300

Conference Reports

300

200

Methodology Articles

500

300

Systematic Reviews or Meta-Analysis

500

300

Book Reviews

300

200

Notes: (1) Click here to find out which group your country falls under. (2) Requests for waivers or discounts must be included in the cover letter during manuscript submission.

Note: For articles over the prescribed word limit (as shown in the table below), we will charge an additional $99.00 US dollars article processing charge for every 0-500 words over the limit. We will charge an additional $59 for each additional table or figure over the prescribed limit due to additional work required. Our goal is to ensure that all submissions comply with the prescribed word limit so that the need for extra publication charges does not arise. We will review manuscripts and determine the costs beforehand. Any overage charges should be discussed and an amount agreed upon at the time of article submission. We will not charge our authors without their interest or consent. Please contact the editorial office for any questions about this: submissions@mchandaids.org.

Country Classification: To determine where your country falls, please visit the World Bank Country and Lending Groups here.


Scroll to top

Word Limits

Word limit table for different articles

Article Type

Word Limit*

References

Tables, Figures, & Images

Letters to the Editor

700

5

1

Original Research

3,000

30

3

Editorials, Commentaries & Viewpoints

1,500

15

2

Short Research Communication

1,000

10

2

Field Studies, Notes from the Field & Case Reports

1,000

10

2

Public Health Policy & Practice

3,000

30

3

Conference Reports

1,000

10

1

Methodology Articles

3,000

30

3

Systematic Reviews or Meta-Analysis

3,500

45

4

Book Reviews

700

5

1

*Notes: (1) The stated word limits exclude Article title, Author information, Abstracts, keyword, and References. (2) Journal templates for each article type are available on the journal website.

Waivers/Discounts: Discounts, waivers, and special considerations may be granted to all authors, especially for authors from developing countries. To the best of our ability, we do not want the inability to pay to limit the publication of important research work. Discounts or waivers should be discussed and an amount agreed upon at the time of article submission.


Scroll to top

Ethical Guidelines

To maintain high scientific quality, our editorial processes and practices follow guidelines/policies issued and updated by the following organizations: Committee on Publication Ethics (COPE); International Committee of Medical Journal Editors (ICMJE), Council of Scientific Editors (CSE); and World Association of Medical Editors (WAME). To read more about this information, click here.

· Open Access: In addition to strict compliance with the above guidelines, our open-access publishing practices follow best practices, guidelines, and policies outlined in The Principles of Transparency and Best Practice in Scholarly Publishing issued by COPE, Open Access Scholarly Publishers Association (OASPA), and Directory of Open Access Journals (DOAJ).

IJMA is indexed in DOAJ and will be subjected to the required evaluation and re-evaluation for open-access publishing best practices as established and updated by DOAJ.

This journal will subscribe to and comply with best practices for open-access publishers as established and advocated by OASPA.

Authors should describe in detail all-new experimental and non-experimental research methods and ethically relevant aspects of their work bearing in mind the following:

Human Experiments

All work must be conducted in accordance with the Declaration of Helsinki (1964). Papers describing experimental work on human subjects who carry a risk of harm must include the following statement:

“I/we declare that the experiment described in this manuscript was conducted with the understanding and the consent of the human subject.”

In addition, please add a statement that the responsible Ethical Committee or Institutional Review Board has reviewed and approved the study/experiments.

Animal Experiments

Papers describing experiments on living animals should provide information on the following:

  • A full description of any anesthetic and surgical procedure used.
  • Evidence that all possible steps were taken to avoid animal suffering at each stage of the experiment. Papers describing experiments on isolated tissues must indicate precisely how the donor tissues were obtained.

In all cases, IJMA reserves the right to ask authors for more information about their treatment of human and animal subjects in their work before publication.

IJMA is one of the few scientific journals in the world that endorses the principles and guidelines for reporting preclinical research led by the U.S. National Institutes of Health (NIH). Click here to read more about this guideline and its implications for your manuscript submission.

IRB Approval

IJMA requires that all studies that involve human subjects or participants be approved or deemed exempt by an official institutional review board or ethics review board as applicable in the authors’ country. Information about ethical approvable must be clearly stated in the Methodology section of the manuscript before submission.

Informed Consent

IJMA requires that authors obtain requisite informed consent and/or assent or other applicable consent from all human subjects or participants in their study. Authors are required to state whether and how informed consent/assent was obtained in their study in their manuscript.

In reporting their studies, authors should avoid the use of names, initials, and hospital numbers of patients/volunteers or study participants or subjects. In very rare circumstances where the authors are submitting photographs of study participants, these individuals should not be recognizable from photographs unless their written permission has first been obtained.

Please contact the editorial office submissions@mchandaids.org before submitting any videos, photographs, or other images of study participants.


Scroll to top

Compliance with ICMJE Recommendations

IJMA adheres to the finest editorial principles to ensure that the work it publishes is accurate, timely, fair, and conforms to the best ethical principles of publication of scientific papers as outlined here and may be updated from time to time. We believe that principles like those outlined here provide clear and clarity and rigorous guidelines for best working practices in scientific publishing and for ensuring the integrity of the papers that we publish. We believe that these principles and policies will benefit our authors, editors, and readers as we strive for a trustworthy, transparent, and efficient publishing process. IJMA Editor-in-Chief is a member of the World Association of Medical Editors, a global nonprofit voluntary association of editors of peer-reviewed medical journals. This ensures that our editorial policies comply with the best practices in medical and scientific publishing across the world,

Confidentiality

Editors and reviewers are expected to treat articles they handle confidentially. Editors and reviewers must not disclose information about manuscripts (including their receipt, content, status in the publishing process, reviewer feedback, and final decision) to anyone, other than the authors.

Objectivity and Fair Play

An editor will evaluate manuscripts for their intellectual content without regard to race, gender, sexual orientation, religious belief, ethnic origin, citizenship, or political philosophy of the authors. Reviews should be conducted objectively. Personal criticism of the author is inappropriate. Referees should express their views clearly with supporting arguments.

Integrity of the Scientific Record

IJMA is committed to maintaining the integrity of the published record, and to publishing the most objective and unbiased scientific information possible. As such, we subscribe to the principles adopted by the Committee on Publication Ethics (COPE) and follow the COPE’s Code of Conduct.

Research misconduct includes fabrication, falsification, or plagiarism in proposing, performing, or reviewing research, or in reporting research results, according to experts. If a suspicion or allegation of scientific misconduct or fraudulent research is brought to the journal’s attention concerning a manuscript submitted for review, IJMA reserves the right to raise these concerns with other relevant institutions or other appropriate authorities for investigation. In the handling and resolution of such cases, we follow COPE’s guidance and recommendations

IJMA will take all necessary steps to maintain the accuracy and quality of the papers it publishes. To this end, IJMA will publish correspondence about papers and publish Errata and Corrigenda when appropriate. In cases of serious error or scientific misconduct, it may be necessary to ask authors to retract their papers or to impose retraction upon them. Should an author discern a significant error or inaccuracy in the published article, they are responsible for notifying IJMA Editor-in-Chief or publisher, and should work together with them to retract or correct the paper. If the Editor-in-Chief or the publisher learns that a published article contains a significant error, the author will be asked to correct or possibly retract the paper, or assist verification by the Editor-in-Chief of the correctness of the original paper.

Errata and Corrigenda

Should an error appear in a published article that affects the scientific meaning or author credibility but does not affect the overall results and conclusions of the paper, our policy is to publish a correction in print and online in the next available issue of the journal. If an error is introduced by the publisher during the editing and/or proofing stages, the journal takes responsibility and a correction is published as an Erratum, with appropriate apologies to authors and readers. If an error is introduced by the authors, the correction is published as a Corrigendum and the author is required to pay all costs associated with the correction.

Retractions

Should a paper contain one or more significant errors or inaccuracies that change some or all of the results or conclusions described therein, the entire paper may be retracted. The word ‘retraction’ will be used in the title of the Retraction to ensure that it is picked up by indexing and archiving systems. The journal will request an explanation from the author(s) as to how the errors or inaccuracies occurred, and if they are not satisfied with the response they will ask the employers of the authors or some other appropriate body to investigate, and particularly to consider the possibility of fraudulent behavior. The journal will make all reasonable attempts to ensure that such an investigation is carried out with due diligence. To the extent possible, we will assist the parties and their institutions in the resolutions of these cases.

Should an author discern a significant error or inaccuracy in the published article, they are responsible for notifying IJMA and should work together with the journal to retract or correct the paper. If the journal learns that a published article contains a significant error, the author will be asked to correct or possibly retract the paper, or assist verification by the Editor-in-Chief of the correctness of the original paper.

Redundant or Concurrent Publication

Research manuscripts that describe work already published elsewhere will not be considered. The submission of the same manuscript to more than one journal concurrently is considered to be unethical practice. This does not prevent journals from considering articles that have been rejected by other journals or that were not previously published in full (e.g. abstracts or posters presented at scientific meetings).

When submitting, authors should declare any previous submissions or reports that might be regarded as redundant or duplicate publication. Copies of any such related articles should be included with the submitted manuscript to assist editorial decision-making. If the redundant publication is attempted or occurs, editorial action will be taken, including probable rejection or publication of a notice of redundant or duplicate publication.

Anti-Plagiarism

Plagiarism is the “use of others’ published and unpublished ideas or words (or other intellectual property) without attribution or permission, and presenting them as new and original rather than derived from an existing source” see www.wame.org – the World Association of Medical Editors web site). It is considered a dishonest and unacceptable practice. By submitting an article, authors are thereby asserting that their work is entirely original and that others’ work or text has been appropriately cited or attributed.

IJMA is committed to the publication of high-quality, original, research in the field of MCH and HIV/AIDS, and public health in general. The journal editors and publisher will take every step to ensure that, to the best of their knowledge, papers published in the journal are original and conform to the best ethical principles. This includes the use of proprietary and open-source anti-plagiarism screening services and software to verify the originality of content submitted before publication. Manuscripts found to have been plagiarized will be automatically rejected and the editors reserve the right to notify appropriate agencies or the institutions of the corresponding authors.

Author Contributions

IJMA complies with the International Committee of Medical Journal Editors guidelines in the definition of authorship. An author is someone who has made significant and substantial contributions to a study. This should include conception, design, execution, and interpretation of the findings being published, and drafting and revising the article. Papers must be submitted with the agreement of all authors, and all authors should give final approval of the version to be published. Those who have made other contributions to the work, such as by providing reagents or assisting with the writing, should be listed in the Acknowledgements, and their role or involvement outlined. Mentees of authors who participate in our IPMP will be included as authors due to the substantial nature of the methodological and editorial support provided to the mentee in the development of the manuscript and its preparation for peer-review and eventual acceptance.

Open Access: In addition to strict compliance with the above guidelines, our open-access publishing practices follow best practices, guidelines, and policies outlined in The Principles of Transparency and Best Practice in Scholarly Publishing issued by COPE, Open Access Scholarly Publishers Association (OASPA), and Directory of Open Access Journals (DOAJ).

This journal is indexed in DOAJ and will be subjected to the required screening and rescreening for open-access publishing best practices as established and updated by DOAJ.


Scroll to top

Privacy Statement

IJMA is a peer-reviewed, open-access print and online journal published by the Global Health and Education Projects, Inc. (GHEP). GHEP is a US 501(c)(3) non-profit organization that strives to address the social determinants of health and elimination of health disparities across the world.

GHEP publications platform and websites include the various components referred to above including all journal content products, services, features, functionalities, content related sites, and other information accessible through the IJMA Network portal [whether provided by GHEP or any third party], related sites include IJMA on Facebook, IJMA on Twitter, IJMA on Linkedin, e-mail addresses and other personal information. The GHEP websites and IJMA portal are committed to preserving site visitors’ privacy of personal information. The IJMA portal does not collect personal information from a site visitor unless that visitor explicitly and intentionally provides it.

Collection, retention, and use of personal information about site visitors will occur if you choose to interact with the GHEP. for example, you can choose to subscribe to IJMA and/or the IJMA resources, receive e-mail notifications regarding tables of contents, topic collections, and article alerts whether or not you are a subscriber, or learn about new offerings from the GHEP. Depending on the type of product or service that you request, you may be asked to provide different personal information. The IJMA portal may require your name, address, telephone number, e-mail address, credit card number, Internet protocol (IP) address, and/or other identifying information. Please refer to the appropriate online form for a specific listing of the type of personal information collected.

The GHEP portal may use your personal information collected via the sites (in addition to the e-mail address information use outlined above) for the following purposes:

  • Provide access to journal content.
  • Process, fulfill, and follow up on orders.
  • Answer your e-mails.
  • Send information you request.
  • Send and process surveys.
  • Ensure the GHEP Publications are relevant to your needs.
  • Recommend content that suits you.
  • Notify you about new products/services, special offers, upgrades, and other related information from IJMA and other GHEP Publications.

All e-mail alerts contain an “unsubscribe” option in case you want to discontinue the alert(s) at any time.

The GHEP portal also occasionally hires other companies to provide limited services on our behalf, including, but not limited to, packaging, mailing, and delivering purchases, answering customer questions about products or services, sending postal mail, and processing event registration. We will provide those companies only the information they need to deliver the service, and they are prohibited from using that information for any other purpose.

The GHEP portal may disclose your personal information if required to do so by law or in the good-faith belief that such action is necessary to: (a) conform to legal requirements or comply with legal process served on GHEP; (b) protect and defend the rights or property of GHEP; or (c) protect the personal safety of GHEP personnel or members of the public in urgent circumstances.

In addition to the uses identified above, if the site visitor changes his or her personal information on the GHEP portal, that information may be incorporated into the GHEP database commonly known as the GHEP database.

Advertising. The GHEP websites and portal use third parties to serve advertisements and analyze related data. Non-identifiable website visitor data may be collected and used in aggregate to determine the type of advertisement to be seen by site visitors while on the IJMA portal. Advertisements use persistent cookies (defined below) to identify the number of unique computers from which viewers have viewed an advertisement and to manage the number of times a viewer will see an advertisement and similar advertising efficiencies. No personally identifiable information is collected from the persistent cookie.

Website Analytics. Non-identifiable website visitor data may be collected and used in aggregate to help shape and direct the creation and maintenance of content.

Cookies. A cookie is a small file stored on the site user’s computer or Web server and is used to aid Web page navigation. Session cookies are temporary files created when a user signs in on the website or uses personalized features such as purchasing temporary access to an article or site-wide access. Session cookies are removed when a user logs off or when the browser is closed. Persistent cookies are permanent files and must be deleted manually. Persistent cookies are used on the GHEP portal (1) when a user asks to save the user name and password to prevent the need to enter this information again; (2) by advertisements to identify the number of unique computers from which viewers have viewed an advertisement and to manage the number of times a viewer will see an advertisement and similar advertising efficiencies; (3) by quiz and poll features to determine when an individual has already responded or voted; (4) to retain article preference settings; and (5) to maintain shopping cart items. No personally identifiable information is collected from the latter persistent cookie, and only the user name and password are collected for the former persistent cookie and the session cookie; (3) Electronic Store Shopping Cart; and (4) Web Analytics measuring time or site and number of visits.

E-mail messages. E-mail messages sent to or from a website may not be secure. Confidential information should not be sent by e-mail. Site visitors sending e-mail accept the risk that a third party may intercept e-mail messages.

You may opt-out of any future contacts from us at any time. Contact us via the phone number or contact form on our website at any time to:

  • See what data we have about you if any;
  • Change/correct any data we have about you;
  • Ask us to delete any data we have about you; and/or
  • Opt-out of some or all future communications from us.

If you have any additional questions or concerns about this privacy policy, please contact us via the phone number listed on this website.

User-Generated Content. Any data or personal information that You submit to us as user-generated content becomes public and may be used by GHEP in connection with GHEP network/friends our digital applications, and other IJMA publications in any media.

Policy Revisions. As the GHEP portal evolves, this Privacy Policy is expected to change as well. The GHEP reserves the right to amend this Privacy Policy at any time, for any reason. We will post a notice that this Policy has been amended by revising the “last updated” date at the top of the Privacy Policy.

Online Policy. This Privacy Policy applies ONLY to information collected via The GHEP portal by the organization or those that it may hire to provide limited services on our behalf.

Credit card privacy. All credit card transactions are conducted over a secure system. Only authorized personnel with specific identification and passwords can access credit card information solely to perform adjustments or refunds at the customer’s request.

Limitation of Liability. Neither GHEP, which owns IJMA, the open-access journal, and the IJMA portal, nor any of its subsidiaries or affiliate entities, agents, employees, or subcontractors shall be liable for any direct, indirect, special, incidental, consequential, punitive, or exemplary damages, including lost profits (even if we are advised of the possibility) arising in any way from the information contained in this Web site or any information transmitted via this web site. The GHEP is not liable for any damages or losses that may be caused to any equipment and other software due to any viruses, defects, or malfunctions in connection with access or use of the IJMA portal websites.

Contact us. We welcome your feedback. If you have questions or comments about our Privacy Policy, please contact us at info@mchandaids.org.

Last Updated: October 30, 2020.


Scroll to top